BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 1850663)

  • 1. T helper cells in cytotoxic T lymphocyte development: analysis of the cellular basis for deficient T helper cell function in the L3T4-independent T helper cell pathway.
    Ciavarra RP
    Cell Immunol; 1991 May; 134(2):427-41. PubMed ID: 1850663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
    Mizuochi T; Golding H; Rosenberg AS; Glimcher LH; Malek TR; Singer A
    J Exp Med; 1985 Aug; 162(2):427-43. PubMed ID: 3160804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
    J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
    Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
    Kern DE; Peace DJ; Klarnet JP; Cheever MA; Greenberg PD
    J Immunol; 1988 Oct; 141(8):2824-30. PubMed ID: 2459230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function.
    Moser M; Mizuochi T; Sharrow SO; Singer A; Shearer GM
    J Immunol; 1987 Mar; 138(5):1355-62. PubMed ID: 2949013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of helper cell-independent cytotoxic T lymphocytes is dependent upon L3T4+ helper T cells.
    Roopenian DC; Anderson PS
    J Immunol; 1988 Jul; 141(2):391-7. PubMed ID: 2968398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T lymphocyte clones that proliferate autonomously to specific alloantigenic stimulation. II. Relationship of the Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine secretion.
    Glasebrook AL; Kelso A; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1545-51. PubMed ID: 6187814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens.
    Guimezanes A; Schmitt-Verhulst AM
    Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cytotoxic activity of alloreactive cytotoxic T lymphocytes by helper cells and lymphokines.
    Ting CC; Loh NN; Hargrove ME
    Cell Immunol; 1986 Sep; 101(2):299-311. PubMed ID: 2944608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysfunction expressed selectively on L3T4+ T cells in the tumor-bearing state.
    Tada T; Sano H; Sato S; Shima J; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1990 Feb; 47(2):149-57. PubMed ID: 1968083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.